The Determinants of CD8 T cell Dysfunction in Oral Cavity Squamous Cell Carcinoma
口腔鳞状细胞癌 CD8 T 细胞功能障碍的决定因素
基本信息
- 批准号:10677361
- 负责人:
- 金额:$ 3.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdvisory CommitteesAntibodiesAntigensAntitumor ResponseBinding SitesCD8-Positive T-LymphocytesCRISPR interferenceCancer ControlCancer EtiologyCancer cell lineCell DeathCell LineCell SeparationCellsChIP-seqChimeric ProteinsChronicClinicalCoculture TechniquesCollagenDNADNA BindingDataData SetDevelopmentElectroporationEpitheliumExclusionFellowshipFlow CytometryFunctional disorderGene ExpressionGene TargetingGenesGenetic TranscriptionGoalsHead and Neck CancerHybridsImmuneImmunologyImmunotherapyIn VitroInfiltrationInflammatoryKnowledgeLibrariesLiteratureMalignant NeoplasmsMapsMeasuresMembraneMentorshipMesenchymalMethodsModelingMorbidity - disease rateOrganoidsOutcomeParacrine CommunicationPatientsPeripheralPhenotypePhysiciansProliferatingProtein SecretionProteinsRNAReceptor ActivationRecurrenceResearchResistanceRoleSamplingScientistSignal TransductionSmokingSurvival RateSystemT cell infiltrationT cell responseT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticThymocyte SelectionTissue-Specific Gene ExpressionTrainingTransposaseTumor-DerivedWorkanti-PD-1cancer cellcancer therapycancer typecell typecheckpoint inhibitioncytokinecytotoxicityexhaustexhaustionexperimental studyfunctional restorationhybrid proteinimmune checkpointimmunocytochemistryimprovedinsightknock-downmalignant mouth neoplasmmortalitymouth squamous cell carcinomanew therapeutic targetnovelprogenitorprognosticprotein expressionresponsesingle-cell RNA sequencingstemtherapeutic targettranscription factortranscriptome sequencingtreatment strategytumorvector control
项目摘要
PROJECT SUMMARY
Head and neck cancer, including oral cavity squamous cell carcinoma (OCSCC), is the sixth leading cause of
cancer and a major cause of morbidity and mortality. Unfortunately, the five-year survival rate of OCSCC has
only slightly improved in the past 30 years. Recently, immune checkpoint inhibition (ICI) therapies have emerged
as a promising treatment to improve OCSCC outcomes, yet only 14-22% of OCSCC patients respond to ICI.
Thus, delineating the mechanisms of ICI resistance represents an opportunity to identify novel targets that may
increase ICI efficacy and improve OCSCC patient survival. CD8 T cells are the primary immune cell type that
kills malignant cells during ICI, and their dysfunction may contribute to ICI resistance. During the chronic
response to a tumor, CD8 T cells enter an exhausted cell state – a dysfunctional phenotype characterized by
decreased ability to lyse target cells. Expression of the transcription factor thymocyte selection-associated HMG
box (TOX) is critical for inducing CD8 T cell exhaustion and is enriched in the exhausted CD8 T cell subset within
single cell RNA-seq datasets of OCSCC patient tumor samples. The genes that are directly transcriptionally
regulated by TOX that promote CD8 T cell dysfunction and may be therapeutically targeted, however, remain
poorly defined. In addition to TOX, malignant cell signals may contribute to CD8 T cell dysfunction and ICI
resistance. We discovered a hybrid epithelial/mesenchymal (HEM) malignant cell state in OCSCC that localizes
to the tumor edge adjacent to CD8 T cells and is associated with exhaustion of these adjacent CD8 T cells. The
mechanisms of HEM cells underlying this association are not well understood. The primary hypothesis of this
proposal is that CD8 T cell dysfunction in OCSCC is driven by the direct gene targets of TOX in CD8 T cells and
by immunosuppressive contact and paracrine signaling from HEM cells. The goal of this proposal is to define
mechanisms of CD8 T cell dysfunction that may be targeted to improve ICI through the following Aims: In Aim 1,
the direct gene targets of TOX and their role in CD8 T cell dysfunction will be defined in vitro using CD8 T cells
isolated from OCSCC samples. In Aim 2, patient-derived CD8 T cells will be co-cultured with patient-matched
OCSCC tumor-derived organoids or cancer cell lines expressing a model antigen. In these co-cultures, HEM-
specific membrane and secreted proteins will be knocked-down in the malignant cells to determine their role in
suppressing CD8 T cells. The proposed research will provide mechanistic insight into CD8 T cell dysfunction in
OCSCC, thereby supporting development of new strategies to therapeutically activate CD8 T cells and improve
ICI and OCSCC outcomes. Importantly, during this fellowship, I will pursue scientific and clinical activities under
the direct mentorship of a comprehensive fellowship advisory committee composed of physician-scientists and
experts in cancer and immunology research. My proposed training will be vital to accomplishing my goal of
investigating cancer-immune interactions and maturing as an independent, academic physician-scientist.
项目摘要
包括口腔鳞状细胞癌(OCSCC)在内的头颈部癌症是导致口腔癌的第六大原因。
癌症和发病率和死亡率的主要原因。不幸的是,OCSCC的五年生存率
在过去的30年里只略有改善。最近,出现了免疫检查点抑制(ICI)疗法,
作为改善OCSCC结局的有希望的治疗,但只有14-22%的OCSCC患者对ICI有反应。
因此,描绘ICI抗性的机制代表了一个机会,以确定新的目标,
增加ICI功效并改善OCSCC患者存活率。CD 8 T细胞是主要的免疫细胞类型,
在ICI期间杀死恶性细胞,并且它们的功能障碍可能有助于ICI抗性。在慢性
在对肿瘤的应答中,CD 8 T细胞进入耗竭细胞状态-一种功能失调的表型,其特征在于
降低裂解靶细胞的能力。胸腺细胞选择相关转录因子HMG的表达
框(TOX)对于诱导CD 8 T细胞耗竭是关键的,并且在CD 8 T细胞亚群中富集。
OCSCC患者肿瘤样品的单细胞RNA-seq数据集。直接转录的基因
然而,由TOX调节的促进CD 8 T细胞功能障碍并且可能是治疗靶向的,
定义不好。除TOX外,恶性细胞信号可能导致CD 8 T细胞功能障碍和ICI。
阻力我们在口腔鳞状细胞癌中发现了一种上皮/间质混合型(HEM)恶性细胞状态,
与邻近CD 8 T细胞的肿瘤边缘相关,并与这些邻近CD 8 T细胞的耗竭相关。的
HEM细胞在这种关联下的机制还没有很好地理解。这个问题的主要假设是
提出OCSCC中的CD 8 T细胞功能障碍是由CD 8 T细胞中TOX的直接基因靶标驱动的,
通过免疫抑制接触和HEM细胞的旁分泌信号。该提案的目的是定义
通过以下目的可以靶向改善ICI的CD 8 T细胞功能障碍的机制:在目的1中,
TOX的直接基因靶点及其在CD 8 T细胞功能障碍中的作用将使用CD 8 T细胞在体外确定
分离自口腔鳞状细胞癌样本。在目标2中,将患者来源的CD 8 T细胞与患者匹配的CD 8 T细胞共培养。
OCSCC肿瘤衍生的类器官或表达模型抗原的癌细胞系。在这些共同培养中,
特异性膜和分泌的蛋白质将在恶性细胞中被敲低,以确定它们在恶性细胞中的作用。
抑制CD 8 T细胞。拟议的研究将提供机制洞察CD 8 T细胞功能障碍,
OCSCC,从而支持开发治疗性活化CD 8 T细胞并改善
ICI和OCSCC结果。重要的是,在这个奖学金,我将追求科学和临床活动下,
由医生-科学家组成的综合研究金咨询委员会的直接指导,
癌症和免疫学研究专家。我所建议的训练对我实现
研究癌症与免疫的相互作用,并成为一名独立的学术医生和科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Riley Dalton Zale Mullins其他文献
Riley Dalton Zale Mullins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 3.44万 - 项目类别:
Standard Grant